Navigation Links
Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility

REDWOOD CITY, Calif., March 19, 2012 /PRNewswire/ -- Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced that the Weill Cornell Medical College has chosen Ingenuity Variant Analysis and Ingenuity iReport for use in its sequencing core facility.  Variant Analysis will be used to identify causal variants from the output of whole genome and exome sequencing experiments and iReport will be used for the biological interpretation of RNA-Seq and other gene expression data.

The ability to rapidly and reliably identify causal variants and relevant pathways from NGS studies is imperative for realizing the full value of NGS platforms. The Ingenuity NGS offerings leverage the unique and proprietary Ingenuity® Knowledge Base to provide researchers with a rapid and evidence-backed biological analysis of their NGS experiments.

Ingenuity Variant Analysis offers a unique combination of filtering, analytics, and richly annotated content that allows researchers to identify and prioritize variants by drilling down to a small, targeted subset of compelling variants based both upon published biological evidence and the researcher's own knowledge of disease biology. Researchers working with RNA-Seq data can use Ingenuity iReport to quickly and accurately determine key affected pathways and biological processes, and understand the molecular and genetic basis of observed gene expression changes – all with peer-reviewed literature support. 

"Pathway analysis is essential for elucidating the molecular networks affected by rare variants and for discovering the compounding, perturbing effects within biological processes which encompass many genetic loci," stated Christopher Mason, Ph.D., Assistant Professor, Institute for Computational Biomedicine, Cornell University. "Ingenuity Variant Analysis enables us to rapidly identify the most compelling variants from an NGS resequencing study, and Ingenuity iReport makes rich biology and networks underlying an RNA-Seq study really approachable and intuitive. Both solutions provide a unique combination of filtering, analytics, and deep expert-curated annotation content, so we can quickly prioritize variants and genes of interest."

"Cornell and the Mason laboratory are pioneering in clinical applications of NGS for the benefit of patients," stated Doug Bassett, Ph.D., Chief Scientific Officer and Chief Technology Officer, Ingenuity Systems. "It has been a pleasure working with Cornell researchers in the development of our new NGS product capabilities—and we are pleased to have these new products leveraged as part of their NGS core laboratory offering."

For a limited time, Core Labs interested in providing iReport and Variant Analysis can receive a special introductory offer from Ingenuity. Contact us at to learn more, or join us in booth #209 at the ABRF Conference in Orlando, Florida, March 17-20. Our lunchtime presentation (Monday, March 19, 12:00 – 1:00 p.m.) features Dr. Eric Rappaport, Core Lab Director at Children's Hospital in Pennsylvania, and Dr. Russ Carmical, Assistant Professor, Biochemistry and Molecular Biology and Senior Scientist in the Molecular Genomics Core at The University of Texas Medical Branch at Galveston. For more information on Ingenuity iReport or Ingenuity Variant Analysis, please visit

About Ingenuity® Systems
Ingenuity Systems is a leading provider of information and analysis solutions for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers.  For more information visit:

SOURCE Ingenuity Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
2. Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Boston University Biomedical Engineers Find Chink in Bacterias Armor
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):